instrument_fundamentals
date | Close | change | Change (%) | instr__open | High | Low |
---|
instr__news

Is Gilead Sciences, Inc. (GILD) a Best Biotech Stock According to Billionaires?

Is Gilead Sciences, Inc. (GILD) The Most Undervalued NASDAQ Stock To Buy According To Hedge Funds?

Sovereign Investment Advisors LLC Acquires New Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Cibc World Markets Corp

GLOBALT Investments LLC GA Increases Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Envestnet Portfolio Solutions Inc.

Natixis Advisors LLC Grows Position in Gilead Sciences, Inc. (NASDAQ:GILD)

EverSource Wealth Advisors LLC Purchases 167 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

AZN to Acquire EsoBiotec for $1B to Develop In Vivo Cell Therapies - March 17, 2025 - Zacks.com

GILD Stock Trading Close to Its 52-Week High: Should You Buy or Sell? - March 17, 2025 - Zacks.com

Glenview Trust co Decreases Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Stake Raised by Globeflex Capital L P

Poinciana Advisors Group LLC Acquires Shares of 3,212 Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Intact Investment Management Inc.

Madison Investment Advisors LLC Buys New Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Investors Purchase High Volume of Gilead Sciences Call Options (NASDAQ:GILD)

Frank Rimerman Advisors LLC Acquires 232 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) is Globeflex Capital L P's 2nd Largest Position

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Lbp Am Sa

Integras Partners LLC Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences Sees Unusually High Options Volume (NASDAQ:GILD)

Calls of the Day: Shake Shack, Starbucks, 3M, Gilead Sciences, Eli Lilly

Lbp Am Sa Grows Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Integras Partners LLC Buys Shares of 31,045 Gilead Sciences, Inc. (NASDAQ:GILD)

Avantax Advisory Services Inc. Lowers Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences - Leader in HIV Medicines

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Farther Finance Advisors LLC

34,912 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by JPL Wealth Management LLC

Erste Asset Management GmbH Sells 18,055 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Connor Clark & Lunn Investment Management Ltd.

Avantax Advisory Services Inc. Lowers Position in Gilead Sciences, Inc. (NASDAQ:GILD)

This company stands out for investors looking to invest in US markets

A rare Nasdaq gem with consistent returns across time horizons

Once-Yearly Lenacapavir PrEP a Safe, Promising Alternative to Twice-Yearly Dosing

Insider Selling: Gilead Sciences, Inc. (NASDAQ:GILD) CFO Sells 17,929 Shares of Stock

Gilead Sciences - Women's History Month Celebrated With Its Team

Why Gilead Sciences, Inc. (GILD) is the Best Pharma Stock to Buy According to Hedge Funds

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Achmea Investment Management B.V.

Vestcor Inc Has $20.16 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Swiss National Bank

Wealthfront Advisers LLC Lowers Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Citizens Financial Group Inc. RI Purchases 3,706 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Follow the Leader: 2 Biopharma Stocks Showing Relative Strength in 2025

Analyst Says Gilead Sciences (GILD) is a 'Big Liquid' Stock You Should Pay Attention To - Insider Monkey

Gilead Sciences (NASDAQ:GILD) Given New $130.00 Price Target at Morgan Stanley

Gilead's capsid revolution meets our capsid solutions: Sino Biological - Engineering the tools to outsmart HIV

Gilead Sciences' annual HIV prevention injection shows promise in clinical trial, Lancet study reveals

Great Lakes Advisors LLC Has $90.63 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Stake Raised by HighTower Advisors LLC
Gilead Sciences (NASDAQ:GILD) Is Increasing Its Dividend To $0.79

Natural Investments LLC Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

Yearly Injection To Protect Against HIV? Gilead's Lenacapavir Shows Promise In Clinical Trial

Personal CFO Solutions LLC Buys New Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Edgestream Partners L.P. Sells 14,668 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Proficio Capital Partners LLC Acquires Shares of 339,489 Gilead Sciences, Inc. (NASDAQ:GILD)

Bernstein Reaffirms Their Buy Rating on Gilead Sciences (GILD) | Markets Insider

GILD Data on Once-Yearly Lenacapavir for HIV Prevention Positive - March 12, 2025 - Zacks.com

The Zacks Analyst Blog Highlights Exelon, Gilead Sciences, Plains All American Pipeline, Sportradar and Cintas

Gilead Presents Encouraging Long-term Data For Biktarvy In People With HIV And HBV Coinfection

Gilead's Phase 1 Data Shows Promise For Once-Yearly Lenacapavir In HIV Prevention

Top 10 Stocks Wall Street is Discussing

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, Morgan Stanley Analyst Says

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Dearborn Partners LLC

Channing Capital Management LLC Cuts Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

NVO Stock Down 9% as CagriSema Misses Target in Second Obesity Study - March 11, 2025 - Zacks.com

First Clinical Data for Gilead's Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet - Drugs.com MedNews

These 3 Attractive Stocks Keep Cruising Higher - March 11, 2025 - Zacks.com

Buy 5 Non-Tech High-Flying Nasdaq Stocks Amid Index's Recent Bloodbath - March 11, 2025 - Zacks.com

Gilead Sciences (NASDAQ:GILD) Hits New 12-Month High - Should You Buy?

Daiwa Securities Group Inc. Acquires 39,700 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Ruffer LLP Makes New $6.50 Million Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

AlphaQuest LLC Raises Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

M. Kulyk & Associates LLC Sells 11,801 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Jackson Hole Capital Partners LLC Raises Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Investors Research Corp Has $1.07 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Ranch Capital Advisors Inc. Purchases 7,153 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Daiwa Securities Group Inc. Raises Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Argentarii LLC Buys Shares of 3,293 Gilead Sciences, Inc. (NASDAQ:GILD)

Bank Julius Baer & Co. Ltd Zurich Sells 36,080 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Zacks Investment Ideas feature highlights: Gilead Sciences and Johnson & Johnson - March 10, 2025 - Zacks.com

LLY/INCY Olumiant Shows Superior Efficacy in Pediatric Alopecia Study - March 10, 2025 - Zacks.com

Is Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year? - March 10, 2025 - Zacks.com

EC Approves Bristol Myers' Opdivo Plus Yervoy for First-Line HCC

Ruffer LLP Invests $6.50 Million in Gilead Sciences, Inc. (NASDAQ:GILD)

OFI Invest Asset Management Purchases New Shares in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Stake Raised by Dorsey & Whitney Trust CO LLC

Lifeworks Advisors LLC Raises Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

River Global Investors LLP Sells 7,892 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Intellectus Partners LLC Sells 6,025 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Amundi

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by Aviance Capital Partners LLC
Latest news

Oil Market Today: Oil prices surge amid rising tensions in the Red Sea

Bank of Japan to discuss economic risks associated with the Trump trade war

Dow Jones futures decline following a Nasdaq rally led by Tesla and Nvidia